Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
T24 Antigen for Diagnosing or Treating Taenia solium Cysticercosis
Case ID:
TAB-2664
Web Published:
12/6/2022
In order to develop a simple detection assay for field use, CDC researchers cloned and sequenced the
Taenia solium
T24 diagnostic protein. The T24 sequences can be used to detect and diagnose
T. solium
infection or can be formulated into a pharmaceutical composition.
T. solium
is a species of tapeworm. Intestinal infection with
T. solium
is referred to as taeniasis. Many taeniasis infections are asymptomatic but may be characterized by insomnia, anorexia, abdominal pain and weight loss. Cysticercosis infection, which can be fatal, may develop if
T. solium
larvae migrate out of the intestine and form cysticerci in various body tissues. This technology may be used to develop a diagnostic, vaccine, or therapeutic for infection related to
T. solium
.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/T24_Antigen_for_Diagnosing_o r_Treating_Taenia_solium_Cysticercosis
Keywords:
AFXXXX
ANTIGEN
CDC Docket Import
CDC Docket Import CDC Prosecuting
CGH-DPDM
Cysticercosis
DA2XXX
DAXXXX
DB2XXX
DBXXXX
DC2XXX
DCXXXX
Immunodiagnosis
SOLIUM
T24
TAENIA
UBXXXX
UXXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Jeremiah Mitzelfelt
LPM
NIH Technology Transfer
301-443-8518
jeremiah.mitzelfelt@nih.gov